-

LaVoieHealthScience Returns to BIO International to Lead High Demand Session on Building Successful Presentations for Investors & Strategic Partners

Session showcases how to tell your value story and gain support for your company’s product offering

BOSTON--(BUSINESS WIRE)--LaVoieHealthScience today announced it will lead an educational session at the 2025 BIO International Convention, taking place June 16–19 at the Boston Convention & Exhibition Center. Donna LaVoie, President & CEO of LaVoieHealthScience, who led this workshop at BIO International for 17 years, will join Elise Simard, expert corporate coach and trainer, as co-presenter.

“More important than ever, companies need to articulate their value proposition as well as their competitive position in the marketplace," Donna LaVoie, President & CEO of LaVoieHealthScience

Share

“What investors/strategic partners want in 2025: Building presentations for success.”

Wednesday, June 18, 2025
9:00–10:00 AM ET
Boston Convention & Exhibition Center
Room 252AB | Business Development & Investment Breakout Session

Back by popular demand, this high-impact session returns to BIO and will guide health and science executives through a proprietary framework developed by LaVoieHealthScience: The LHS Fifteen-Slide Presentation®. These methodologies are designed to help companies clearly articulate the company value proposition, the market problem, the company’s value solution, competitive differentiation, regulatory approach, and financial vision—all within a concise 15-slide structure.

“More important than ever, companies need to articulate their value proposition as well as their competitive position in the marketplace. The ability to communicate with clarity, confidence, and strategic intent is a leadership imperative in today’s health and science environment,” said Donna LaVoie, President & CEO of LaVoieHealthScience. “The LHS Fifteen-Slide Presentation® equips executives with a powerful blueprint to deliver high-impact messages across critical stakeholders—from investors and strategic partners to board members and future employees.”

In addition to storytelling strategy, the session will offer practical guidance on enhancing presentation skills, building an authoritative voice, and using emotional intelligence to create alignment between verbal and non-verbal communication. Attendees will leave with actionable techniques to elevate their company story and deliver it with credibility and impact.

About LaVoieHealthScience

LaVoieHealthScience partners with emerging, government, and commercial organizations to protect reputation and to advance their missions. We are a team of specialized leaders who possess a love for the ‘why’. The complexity of the business of science, medicine, and technology requires leaders to create a unique voice in a highly related industry. We guide leaders using our 20+ years of history with modern perspectives and time-tested results. Our programs include strategic positioning, public relations and marketing, investor relations, corporate communications, event management, and digital and creative services. For more information, please visit lavoiehealthscience.com and connect with us on LinkedIn and X.

Contacts

Agency Contact:
Lisa DeScenza
SVP, Business Development & Marketing
(617) 351-0243
ldescenza@lavoiehealthscience.com

Media Contact:
Andrew Korda
Account Director, Communications & PR
(617) 865-0043
akorda@lavoiehealthscience.com

LaVoieHealthScience


Release Versions

Contacts

Agency Contact:
Lisa DeScenza
SVP, Business Development & Marketing
(617) 351-0243
ldescenza@lavoiehealthscience.com

Media Contact:
Andrew Korda
Account Director, Communications & PR
(617) 865-0043
akorda@lavoiehealthscience.com

More News From LaVoieHealthScience

LaVoieHealthScience Appoints Seasoned Public Relations Health Agency Leader to its Leadership Team

BOSTON--(BUSINESS WIRE)--LaVoieHealthScience (LHS), a leading consulting agency specializing in strategic communications for health, technology and science enterprises as well as government agencies, announces the addition of Nina Gill as Senior Vice President, Public Relations & Communications. With more than 20 years of success in agency and client leadership as well as in developing, managing, and executing on strategic communications programs, Nina joins LHS at a momentous time in the a...

LaVoie Strategic Communications Group, Inc. Awarded GSA Schedule Contract to Provide Public Relations, Marketing and Training to Federal Agencies

BOSTON--(BUSINESS WIRE)--LaVoie Strategic Communications Group, Inc., widely recognized in the health, science, and medical technology industry as LaVoieHealthScience, has been awarded the first five-year option period of a twenty-year General Services Administration (GSA) Multiple Award Schedule (MAS) contract (Contract Number 47QRAA25D0070) to provide public relations, marketing, and leadership training services to the Federal Government, with an estimated value of $4 million. Under this desi...

LaVoieHealthScience Awarded Best Pharma Product Launch at 2024 PRWeek Healthcare Awards

BOSTON & NEW YORK--(BUSINESS WIRE)--LaVoieHealthScience (LHS) is honored to be awarded with the prestigious title of "Best Pharma Product Launch (Non-OTC)” at this year’s PRWeek Healthcare Awards on May 21. This award is for the partnership with Menarini Stemline from the 2023 launch of ORSERDU® (elacestrant) for the treatment of postmenopausal women or adult men with estrogen receptor (ER)-positive, human epidermal growth factor 2 (HER2)-negative, ESR1-mutated advanced or metastatic breast can...
Back to Newsroom